Serum Neurofilament Light Chain Levels in the Intensive Care Unit: Comparison between Severely Ill Patients with and without Coronavirus Disease 2019
- PMID: 33377539
- DOI: 10.1002/ana.26004
Serum Neurofilament Light Chain Levels in the Intensive Care Unit: Comparison between Severely Ill Patients with and without Coronavirus Disease 2019
Abstract
There is emerging evidence for multifarious neurological manifestations of coronavirus disease 2019 (COVID-19), but little is known regarding whether they reflect structural damage to the nervous system. Serum neurofilament light chain (sNfL) is a specific biomarker of neuronal injury. We measured sNfL concentrations of 29 critically ill COVID-19 patients, 10 critically ill non-COVID-19 patients, and 259 healthy controls. After adjusting for neurological comorbidities and age, sNfL concentrations were higher in patients with COVID-19 versus both comparator groups. Higher sNfL levels were associated with unfavorable short-term outcome, indicating that neuronal injury is common and pronounced in critically ill patients. ANN NEUROL 2021;89:610-616.
© 2020 American Neurological Association.
Comment in
-
Neurofilament Light Chain in Patients with COVID-19 and Bacterial Pneumonia.Ann Neurol. 2021 Jul;90(1):174-175. doi: 10.1002/ana.26135. Epub 2021 Jun 9. Ann Neurol. 2021. PMID: 34036618 Free PMC article. No abstract available.
Similar articles
-
Clinical Characteristics and Predictors of 28-Day Mortality in 352 Critically Ill Patients with COVID-19: A Retrospective Study.J Epidemiol Glob Health. 2021 Mar;11(1):98-104. doi: 10.2991/jegh.k.200928.001. Epub 2020 Oct 3. J Epidemiol Glob Health. 2021. PMID: 33095982 Free PMC article.
-
Serum neurofilament light chain levels in Covid-19 patients without major neurological manifestations.J Neurol. 2022 Nov;269(11):5691-5701. doi: 10.1007/s00415-022-11233-5. Epub 2022 Jul 4. J Neurol. 2022. PMID: 35781535 Free PMC article.
-
Serum neurofilament light chain (sNfL) values in a large cross-sectional population of children with asymptomatic to moderate COVID-19.J Neurol. 2021 Nov;268(11):3969-3974. doi: 10.1007/s00415-021-10554-1. Epub 2021 Apr 23. J Neurol. 2021. PMID: 33893540 Free PMC article.
-
System-Wide Strategies Were Associated With Improved Outcome in Critically Ill Patients With Coronavirus Disease 2019: Experience From a Large Health-Care Network.Chest. 2021 Mar;159(3):1072-1075. doi: 10.1016/j.chest.2020.10.029. Epub 2020 Oct 21. Chest. 2021. PMID: 33098830 Free PMC article. No abstract available.
-
Evidence-Based Management of the Critically Ill Adult With SARS-CoV-2 Infection.J Intensive Care Med. 2021 Jan;36(1):18-41. doi: 10.1177/0885066620969132. Epub 2020 Oct 28. J Intensive Care Med. 2021. PMID: 33111601 Review.
Cited by
-
No substantial neurocognitive impact of COVID-19 across ages and disease severity: a multicenter biomarker study of SARS-CoV-2 positive and negative adult and pediatric patients with acute respiratory tract infections.Infection. 2024 Oct 1. doi: 10.1007/s15010-024-02406-7. Online ahead of print. Infection. 2024. PMID: 39352661
-
Serum neurofilament light chain as a sensitive biomarker for neuromonitoring during extracorporeal membrane oxygenation.Sci Rep. 2024 Sep 9;14(1):20956. doi: 10.1038/s41598-024-71603-z. Sci Rep. 2024. PMID: 39251725 Free PMC article.
-
Cognitive symptoms after COVID-19.Neurol Perspect. 2021 Dec;1:S16-S24. doi: 10.1016/j.neurop.2021.10.005. Epub 2021 Dec 14. Neurol Perspect. 2021. PMID: 38620975 Free PMC article. Review.
-
Co-ultraPEALut in Subjective Cognitive Impairment Following SARS-CoV-2 Infection: An Exploratory Retrospective Study.Brain Sci. 2024 Mar 20;14(3):293. doi: 10.3390/brainsci14030293. Brain Sci. 2024. PMID: 38539680 Free PMC article.
-
Neurological involvement among non-hospitalized adolescents and young adults 6 months after acute COVID-19.Front Neurol. 2024 Feb 7;15:1345787. doi: 10.3389/fneur.2024.1345787. eCollection 2024. Front Neurol. 2024. PMID: 38385031 Free PMC article.
References
-
- Mao L, Jin H, Wang M, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol 2020;77:683-690.
-
- Helms J, Kremer S, Merdji H, et al. Neurologic features in severe SARS-CoV-2 infection. N Engl J Med 2020;382:2268-2270.
-
- Li YC, Bai WZ, Hirano N, et al. Coronavirus infection of rat dorsal root ganglia: ultrastructural characterization of viral replication, transfer, and the early response of satellite cells. Virus Res 2012;163:628-635.
-
- Gu J, Gong E, Zhang B, et al. Multiple organ infection and the pathogenesis of SARS. J Exp Med 2005;202:415-424.
-
- Xu J, Zhong S, Liu J, et al. Detection of severe acute respiratory syndrome coronavirus in the brain: potential role of the chemokine mig in pathogenesis. Clin Infect Dis 2005;41:1089-1096.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
